BRIEF published on 04/03/2025 at 13:18, 1 year 3 months ago Innate Pharma to Engage in Stifel 2025 Virtual Oncology Forum Biotechnology Immunotherapy Virtual Event Innate Pharma Oncology Forum 2025
BRIEF published on 04/03/2025 at 13:18, 1 year 3 months ago Innate Pharma participera au forum virtuel d'oncologie Stifel 2025 Biotechnologie Immunothérapie Événement Virtuel Innate Pharma Forum D'oncologie 2025
PRESS RELEASE published on 04/03/2025 at 13:13, 1 year 3 months ago INSIDE INFORMATION / OTHER NEWS RELEASES Innate Pharma to participate in 2025 Stifel Virtual Targeted Oncology Forum. Executive team presenting and hosting 1x1 meetings. Focus on innovative cancer immunotherapies Cancer Innate Pharma Immunothérapies Stifel Targeted Oncology Forum
PRESS RELEASE published on 03/28/2025 at 14:37, 1 year 3 months ago Annual financial and audit reports / Annual financial report
PRESS RELEASE published on 03/28/2025 at 14:32, 1 year 3 months ago Rapports financiers et d'audit annuels / Rapport financier annuel
BRIEF published on 03/20/2025 at 07:05, 1 year 3 months ago Innate Pharma annonce une conférence sur les résultats financiers 2024 Résultats Financiers Conférence Téléphonique Cotation Boursière Innate Pharma Immunothérapie Cancer
BRIEF published on 03/20/2025 at 07:05, 1 year 3 months ago Innate Pharma Announces 2024 Financial Results Conference Financial Results Conference Call Stock Market Listing Cancer Immunotherapy Innate Pharma
PRESS RELEASE published on 03/20/2025 at 07:00, 1 year 3 months ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique et un webcast pour présenter ses résultats financiers 2024. Détails de l'événement et informations pratiques disponibles sur www.innate-pharma.com Résultats Financiers Webcast Conférence Téléphonique Innate Pharma Biotechnologies
PRESS RELEASE published on 03/20/2025 at 07:00, 1 year 3 months ago Inside Information / Other news releases Innate Pharma to hold conference call and webcast for full year 2024 financial results on March 27, 2025. Details for participation provided Financial Results Conference Call Biotechnology Webcast Innate Pharma
BRIEF published on 02/17/2025 at 07:07, 1 year 4 months ago Innate Pharma reçoit le statut de "Breakthrough Therapy" de la FDA FDA Innate Pharma Breakthrough Therapy Lacutamab Syndrome De Sézary
Published on 07/14/2026 at 01:45, 8 hours 44 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 10 hours 28 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 11 hours 19 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 12 hours 54 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 14 hours 29 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 10:10, 18 minutes ago FocalPoint and STMicroelectronics enter into a commercial agreement to deliver enhanced GNSS reliability for automotive applications
Published on 07/14/2026 at 10:05, 23 minutes ago Quantinuum, Rolls-Royce, Riverlane and University of Edinburgh Sign Agreement to Explore Quantum Computing for Industrial Design and Simulation
Published on 07/14/2026 at 10:00, 29 minutes ago CEOTRONICS AG receives order worth approximately €2 Million
Published on 07/14/2026 at 09:35, 53 minutes ago ABB invests in Gridcog's digital platform to scale next-generation energy projects
Published on 07/14/2026 at 09:30, 59 minutes ago Strongest first half on record underscores the Nordic Bond market's growing international appeal
Published on 07/13/2026 at 18:00, 16 hours 29 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 16 hours 29 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 16 hours 29 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
